Dan Lu

发表

ATF3, a stress-inducible gene: function and regulation

Dan Lu, 2006 .

Targeting the platelet-derived growth factor receptor α with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: Implications as a potential therapeutic target

Peter Bohlen, Dan Lu, D. Hicklin, 2005, Molecular Cancer Therapeutics.

Drug Delivery and Transport to Solid Tumors

Jessie L.-S. Au, M. Guillaume Wientjes, Dan Lu, 2003, Pharmaceutical Research.

Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.

Peter Bohlen, Dan Lu, P. Bohlen, 2001, Cancer research.

Tumor-Penetrating Microparticles for Intraperitoneal Therapy of Ovarian Cancer

Ze Lu, Max Tsai, Dan Lu, 2008, Journal of Pharmacology and Experimental Therapeutics.

A recombinant, fully human, bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3

Dan Lu, Zhen-ping Zhu, K. Persaud, 2005, Molecular Cancer Therapeutics.

Fab-scFv fusion protein: an efficient approach to production of bispecific antibody fragments.

Peter Bohlen, Dan Lu, Zhen-ping Zhu, 2002, Journal of immunological methods.

Di-diabody: a novel tetravalent bispecific antibody molecule by design.

Peter Bohlen, Dan Lu, P. Bohlen, 2003, Journal of immunological methods.

Down Regulation of CIAPIN1 Reverses Multidrug Resistance in Human Breast Cancer Cells by Inhibiting MDR1

Wen He, Yuqing Xu, Dan Lu, 2012, Molecules.

The effect of variable domain orientation and arrangement on the antigen-binding activity of a recombinant human bispecific diabody.

Dan Lu, Zhen-ping Zhu, Xenia Jimenez, 2004, Biochemical and biophysical research communications.

A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.

Peter Bohlen, Dan Lu, D. Hicklin, 2003, Cancer research.

Tailoring in Vitro Selection for a Picomolar Affinity Human Antibody Directed against Vascular Endothelial Growth Factor Receptor 2 for Enhanced Neutralizing Activity*

Peter Bohlen, Dan Lu, P. Bohlen, 2003, Journal of Biological Chemistry.